Parameter/Group | N | % | Measure | Significance |
---|---|---|---|---|
*First remission duration: overall range, 2–116+; median, 10. | ||||
**Two censored observations (102 and 116 months). | ||||
†Survival: overall range, 4–123 months; median, 37. | ||||
‡Two censored observations (108 and 122 months). | ||||
¶Two censored observations (99 and 102 months). | ||||
NR, no response; NS, not significant; PD, progressive disease. | ||||
Response to first treatment | AgNOR count (mean (SD)) | |||
Complete | 13 | 23.6 | 5.16 (1.86) | NS |
Partial | 20 | 36.4 | 4.06 (1.45) | |
NR or PD | 22 | 40.0 | 5.05 (2.10) | |
First remission duration (months)* | Remission duration (mean (range)) | |||
AgNOR count ≤ 4.4 | 17** | 51.5 | 10 (2–116+) | NS |
AgNOR count > 4.4 | 16 | 48.5 | 14.5 (3–41) | |
Survival (months)† | Survival (median (range)) | |||
AgNOR count ≤ 4.4 | 29‡ | 52.7 | 40 (4–123) | NS |
AgNOR count > 4.4 | 26¶ | 47.3 | 31.5 (4–102) |